Literature DB >> 19901245

Body size and risk of MS in two cohorts of US women.

Kassandra L Munger1, Tanuja Chitnis, Alberto Ascherio.   

Abstract

OBJECTIVE: To examine whether obesity during childhood, adolescence, or adulthood is associated with an increased risk of multiple sclerosis (MS).
METHODS: Women in the Nurses' Health Study (n = 121,700) and Nurses' Health Study II (n = 116,671) provided information on weight at age 18 and weight and height at baseline, from which body mass index was derived. Women also selected silhouettes representing their body size at ages 5, 10, and 20. Over the total 40 years of follow-up in both cohorts combined, we confirmed 593 cases of MS. Cox proportional hazards models, adjusting for age, latitude of residence, ethnicity, and cigarette smoking, were used to estimate the rate ratios and 95% confidence intervals (CI).
RESULTS: Obesity at age 18 (body mass index > or =30 kg/m(2)) was associated with a greater than twofold increased risk of MS (multivariate relative risk(pooled) = 2.25, 95% CI: 1.50-3.37, p trend <0.001). After adjusting for body size at age 20, having a large body size at ages 5 or 10 was not associated with risk of MS, whereas a large body size at age 20 was associated with a 96% increased risk of MS (95% CI: 1.33-2.89, p trend = 0.009). No significant association was found between adult body mass and MS risk.
CONCLUSIONS: Obese adolescents have an increased risk of developing multiple sclerosis (MS). Although the mechanisms of this association remain uncertain, this result suggests that prevention of adolescent obesity may contribute to reduced MS risk.

Entities:  

Mesh:

Year:  2009        PMID: 19901245      PMCID: PMC2777074          DOI: 10.1212/WNL.0b013e3181c0d6e0

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  34 in total

1.  Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells.

Authors:  Chandrashekhar Pasare; Ruslan Medzhitov
Journal:  Science       Date:  2003-01-16       Impact factor: 47.728

2.  Body fat content and 25-hydroxyvitamin D levels in healthy women.

Authors:  Sonia Arunabh; Simcha Pollack; James Yeh; John F Aloia
Journal:  J Clin Endocrinol Metab       Date:  2003-01       Impact factor: 5.958

3.  Obesity: preventing and managing the global epidemic. Report of a WHO consultation.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  2000

4.  Rag-1-dependent cells are necessary for 1,25-dihydroxyvitamin D(3) prevention of experimental autoimmune encephalomyelitis.

Authors:  F E Nashold; K A Hoag; J Goverman; C E Hayes
Journal:  J Neuroimmunol       Date:  2001-09-03       Impact factor: 3.478

5.  Geographic variation of MS incidence in two prospective studies of US women.

Authors:  M A Hernán; M J Olek; A Ascherio
Journal:  Neurology       Date:  1999-11-10       Impact factor: 9.910

6.  Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis.

Authors:  P L De Jager; K C Simon; K L Munger; J D Rioux; D A Hafler; A Ascherio
Journal:  Neurology       Date:  2008-02-13       Impact factor: 9.910

Review 7.  The immunological functions of the vitamin D endocrine system.

Authors:  C E Hayes; F E Nashold; K M Spach; L B Pedersen
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  2003-03       Impact factor: 1.770

8.  Vitamin D deficiency in obese patients and changes in circulating vitamin D metabolites following jejunoileal bypass.

Authors:  H Hey; K H Stokholm; B Lund; B Lund; O H Sørensen
Journal:  Int J Obes       Date:  1982

9.  Vitamin D status and bone histomorphometry in gross obesity.

Authors:  J E Compston; S Vedi; J E Ledger; A Webb; J C Gazet; T R Pilkington
Journal:  Am J Clin Nutr       Date:  1981-11       Impact factor: 7.045

10.  Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis.

Authors:  Vissia Viglietta; Clare Baecher-Allan; Howard L Weiner; David A Hafler
Journal:  J Exp Med       Date:  2004-04-05       Impact factor: 14.307

View more
  113 in total

1.  IL-17 regulates adipogenesis, glucose homeostasis, and obesity.

Authors:  Luis A Zúñiga; Wen-Jun Shen; Barbara Joyce-Shaikh; Ekaterina A Pyatnova; Andrew G Richards; Colin Thom; Sofia M Andrade; Daniel J Cua; Fredric B Kraemer; Eugene C Butcher
Journal:  J Immunol       Date:  2010-10-29       Impact factor: 5.422

Review 2.  Lifestyle and Environmental Factors in Multiple Sclerosis.

Authors:  Lars Alfredsson; Tomas Olsson
Journal:  Cold Spring Harb Perspect Med       Date:  2019-04-01       Impact factor: 6.915

3.  Effect of aerobic interval training on serum IL-10, TNFα, and adipokines levels in women with multiple sclerosis: possible relations with fatigue and quality of life.

Authors:  Motahare Mokhtarzade; Rouholah Ranjbar; Nastaran Majdinasab; Darpan Patel; Mehdieh Molanouri Shamsi
Journal:  Endocrine       Date:  2017-06-14       Impact factor: 3.633

4.  Increased risk of multiple sclerosis among women with migraine in the Nurses' Health Study II.

Authors:  Ilya Kister; Kassandra L Munger; Joseph Herbert; Alberto Ascherio
Journal:  Mult Scler       Date:  2011-08-03       Impact factor: 6.312

5.  Stress and the risk of multiple sclerosis.

Authors:  T Riise; D C Mohr; K L Munger; J W Rich-Edwards; I Kawachi; A Ascherio
Journal:  Neurology       Date:  2011-05-31       Impact factor: 9.910

6.  Obesity during childhood and adolescence increases susceptibility to multiple sclerosis after accounting for established genetic and environmental risk factors.

Authors:  Milena A Gianfrancesco; Brigid Acuna; Ling Shen; Farren B S Briggs; Hong Quach; Kalliope H Bellesis; Allan Bernstein; Anna K Hedstrom; Ingrid Kockum; Lars Alfredsson; Tomas Olsson; Catherine Schaefer; Lisa F Barcellos
Journal:  Obes Res Clin Pract       Date:  2014-03-06       Impact factor: 2.288

Review 7.  Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis.

Authors:  Tomas Olsson; Lisa F Barcellos; Lars Alfredsson
Journal:  Nat Rev Neurol       Date:  2016-12-09       Impact factor: 42.937

8.  The emergence of neuroepidemiology, neurovirology and neuroimmunology: the legacies of John F. Kurtzke and Richard 'Dick' T. Johnson.

Authors:  Eric J Kildebeck; Ram Narayan; Avindra Nath; Howard Weiner; Shin Beh; Peter A Calabresi; Lawrence Steinman; Eugene O Major; Teresa C Frohman; Elliot M Frohman
Journal:  J Neurol       Date:  2016-10-12       Impact factor: 4.849

Review 9.  Gut-brain communication in demyelinating disorders.

Authors:  Sami Sauma; Patrizia Casaccia
Journal:  Curr Opin Neurobiol       Date:  2020-02-15       Impact factor: 6.627

Review 10.  The neuropathology of obesity: insights from human disease.

Authors:  Edward B Lee; Mark P Mattson
Journal:  Acta Neuropathol       Date:  2013-10-06       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.